Evercore ISI analysts updated their “AI Enablers, Adopters and Adapters” stock list. These stocks are screened from the ...

Evercore ISI upgraded Cardinal Health (CAH) to Outperform from In Line with an unchanged price target of $140. The firm sees the company’s ...

The bank upgraded Labcorp's stock on expectations of solid lab volume growth, accretive revenues from Labcorp's Invitae business, and margin expansion in 2025.

Consider investing in companies like Evercore with exposure to large ticket transactions post-Trump victory, despite caution ...

Micron Technologies (MU) is climbing for a second straight day after Nvidia (NVDA) noted that it was using MU’s chips in its ...

Evercore ISI analyst Amit Daryanani notes that App Store revenue grew 13% in December, which was a deceleration from the 17% growth rate in ...

Europe’s automakers face existential threats from EU CO2 rules, China competition, weak sales and factory closures. The ...

Tidal Partners, a mergers and acquisitions advisory firm launched in 2022 by former Centerview Partners dealmakers, has hired investment banker Anand Sankaralingam from Evercore , according to people ...

Evercore ISI raised the firm’s price target on Zimmer Biomet (ZBH) to $113 from $110 and keeps an In Line rating on the ...

David Palmer, Evercore ISI, joins 'Squawk on the Street' to discuss his outlook for restaurants in 2025.

Evercore has a better P/E ratio of 35.63 than the aggregate P/E ratio of 30.62 of the Capital Markets industry. Ideally, one ...

Evercore examined Microsoft's past performance as well, noting four times over the past four years when the company lagged ...